and Bernd Kröger.

A combination of two pharmaceutical ingredients, i.e. leflunomide and teriflunomide is to be considered obvious if the person skilled in the art uses an obvious process to obtain leflunomide that automatically results in – even with a certain delay – both components due to a chemical reaction.

Click here for the full text of this case.

A summary of this case will be posted on http://www.Kluweriplaw.com


_____________________________

To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.